Viewing Study NCT03137550


Ignite Creation Date: 2025-12-24 @ 4:50 PM
Ignite Modification Date: 2026-01-05 @ 6:30 PM
Study NCT ID: NCT03137550
Status: COMPLETED
Last Update Posted: 2022-05-31
First Post: 2017-04-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combined Use of Multiple Biomarkers With Stress Testing to Detect Coronary Artery Disease
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Organization:

Study Overview

Official Title: Combined Use of Multiple Biomarkers With Stress Testing to Detect Coronary Artery Disease
Status: COMPLETED
Status Verified Date: 2022-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: COMBAT-CAD
Brief Summary: Main aim of the COMBAT-CAD-Study is to clarify, if the combination of stress testing with biomarkers improves the diagnostic accuracy.

Hypothesis of our study is that diagnosis of CAD can be improved by adding biomarkers to solely stress testing for the workup of patients with suspected CAD or progress of already known CAD.
Detailed Description: The COMBAT-CAD Study is an observational study with the aim to improve the diagnostic accuracy by a combination of stress testing with sensitive and specific biomarkers in detecting coronary artery disease or its progress. The main subjects are all patients with CAD or suspicion of CAD sent to the University Heart Center Hamburg. In these patients, ECG, laboratory examination, symptoms or transthoracic echocardiography in rest could not rule out CAD or progress of known CAD. The hypothesis of the study is that detection of CAD can be improved by adding biomarkers to stress testing for the diagnostic workup of patients with suspected CAD or progress of already known CAD.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: